Exiqon Diagnostics, Inc
Exiqon Diagnostics, a division of Exiqon A/S, was a leader in personalized medicine for cancer patients. Exiqon Diagnostics was dedicated to developing and performing novel molecular and cell-based oncology assays to help physicians individualize and optimize treatment selection for their patients. Exiqon A/S divested Exiqon Diagnostics in June 2010, resulting in the permanent closure of Exiqon Diagnostics. Subsequently, Exiqon A/S was acquired by Qiagen in 2016.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
51 to 200
headcount range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Exiqon Diagnostics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Exiqon Diagnostics, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Exiqon Diagnostics, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.